[LGND] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
04-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -79.41%
YoY- -88.23%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 13,635 6,375 5,742 5,636 12,936 5,741 7,463 49.17%
PBT 950 -52 -3,728 -522 5,997 -3,884 -773 -
Tax -1,636 142 338 -35 495 22 141 -
NP 1,063 -194 -2,267 1,133 5,502 -3,906 -914 -
Tax Rate 172.21% - - - -8.25% - - -
Total Cost 12,572 6,569 8,009 4,503 7,434 9,647 8,377 30.92%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 7.80 -3.04 -39.48 20.10 42.53 -68.04 -12.25 -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS 0.05 -0.01 -0.11 0.07 0.28 -0.20 -0.05 -
EPS Diluted 0.05 -0.01 -0.11 0.07 0.28 -0.20 -0.05 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.